
Vineti sets a collaboration with Quick for CGT logistics
Better data-sharing for cellular and genetic therapies is the goal
Having established
Cellular and genetic therapies (CGTs), such as those involving CAR-T technology, usually involve extracting cells from a patient, conveying it to a facility where the genetic manipulations are performed, and then returning it to the patient for infusion. “CGTs represent the time that GMP-based processes originate in the clinic,” notes DuRoss. “Our value proposition is to provide a system of record for the entire process.”
Quick and Vineti accompanied the partnership announcement with release of a “tip sheet” for managing CGT processes, available at the Vineti
Related to this article








